News

IBBL's 2013 annual report shows that the progress of the biobank is aided by a clever combination of national and international partnerships.

First clinical application of genome editing technology in hematopoietic stem/progenitor cells.

Noninvasive laser therapy could radically shift dental treatment and lead to a host of broader clinical applications in regenerative medicine.

3D ptychographic method used to visualize 3D specimens up to 34 tomographic sections in depth.

Discovery opens new possibilities for regenerative medicine.

Blocking the stem cell marker slow down the growth of aggressive human brain cancers.

Phase I/II AMD trial on track to complete enrollment in June.

Stem cells contain specific proteins that recognize hydroxymethyluracil and therefore contribute to the regulation of gene activity.

The gift from the Glenn Foundation for Medical Research will allow the Institute to continue conducting research to understand the biology of normal human aging and age-related diseases.

PreciseType™ HEA test becomes the first-ever FDA-approved diagnostic for molecular typing of donor and recipient red blood cells for blood transfusions.